Skip to main content


Page 4 of 26

  1. The aims of this study were to establish a normal database (NDB) for semiquantification of dopamine transporter (DAT) single-photon emission computed tomography (SPECT) with [123I]FP-CIT on a cadmium zinc telluri...

    Authors: Felix Thiele, Franziska Schau, Julian M. M. Rogasch, Christoph Wetz, Stephanie Bluemel, Winfried Brenner, Holger Amthauer, Catharina Lange and Imke Schatka
    Citation: EJNMMI Research 2023 13:24
  2. IgG4-related disease (IgG4-RD) is a heterogeneous autoimmune disorder characterised by inflammatory lesions. Diagnostic imaging, such as 2-[18F]FDG PET/CT, is critical in evaluation of the disease, especially for...

    Authors: Mingwei Chen, Charlene Yu Lin Tang, Warren Weng Seng Fong and Winnie Wing-Chuen Lam
    Citation: EJNMMI Research 2023 13:22
  3. In the development of new 18F-labelled tracers, it is important to assess the amount of released [18F]fluoride taken up in the bones of experimental animals because all 18F-labelled PET-tracers are prone, to less...

    Authors: Nina Savisto, Tove J. Grönroos, Vesa Oikonen, Johan Rajander, Eliisa Löyttyniemi, Jörgen Bergman, Sarita Forsback, Olof Solin and Merja Haaparanta-Solin
    Citation: EJNMMI Research 2023 13:21
  4. PET/MRI hybrid imaging in pulmonary arterial hypertension (PAH) provides important prognostic information identifying patients who might benefit from early therapy escalation, as right ventricle (RV) metabolic...

    Authors: Remigiusz Kazimierczyk, Piotr Szumowski, Stephan G. Nekolla, Lukasz A. Malek, Piotr Blaszczak, Marcin Hladunski, Bozena Sobkowicz, Janusz Mysliwiec and Karol A. Kaminski
    Citation: EJNMMI Research 2023 13:20
  5. Authors: Lisbeth Marner, Kirsten Korsholm, Lasse Anderberg, Markus N. Lonsdale, Mads Radmer Jensen, Eva Brødsgaard, Charlotte L. Denholt, Nic Gillings, Ian Law and Lars Friberg
    Citation: EJNMMI Research 2023 13:19

    The original article was published in EJNMMI Research 2022 12:56

  6. To determine whether the APOE-ε4 allele modulates the relationship between regional β-amyloid (Aβ) accumulation and cognitive change in middle-aged cognitively unimpaired (CU) participants.

    Authors: Anna Brugulat-Serrat, Gonzalo Sánchez-Benavides, Raffaele Cacciaglia, Gemma Salvadó, Mahnaz Shekari, Lyduine E. Collij, Christopher Buckley, Bart N. M. van Berckel, Andrés Perissinotti, Aida Niñerola-Baizán, Marta Milà-Alomà, Natàlia Vilor-Tejedor, Grégory Operto, Carles Falcon, Oriol Grau-Rivera, Eider M. Arenaza-Urquijo…
    Citation: EJNMMI Research 2023 13:18
  7. 44Sc/47Sc is an attractive theranostic pair for targeted in vivo positron emission tomographic (PET) imaging and beta-particle treatment of cancer. The 44Ti/44Sc generator allows daily onsite production of this d...

    Authors: Nadia Benabdallah, Hanwen Zhang, Ryan Unnerstall, Amanda Fears, Lucy Summer, Michael Fassbender, Buck E. Rodgers, Diane Abou, Valery Radchenko and Daniel L. J. Thorek
    Citation: EJNMMI Research 2023 13:17
  8. We aimed to evaluate the correlation between 2-deoxy-2-[18F]fluoro-D-glucose (FDG) uptake and disease activity assessed by serum inflammatory biomarker levels in patients with spondyloarthritis (SpA).

    Authors: Yuri Manabe, Takashi Norikane, Yuka Yamamoto, Mitsumasa Murao, Hiromi Shimada, Risa Wakiya, Shusaku Nakashima, Hiroaki Dobashi and Yoshihiro Nishiyama
    Citation: EJNMMI Research 2023 13:15
  9. By comparing the prognostic performance of 18F-FDG PET/CT-based radiomics combining dose features [Includes Dosiomics feature and the dose volume histogram (DVH) features] with that of conventional radiomics in h...

    Authors: Bingzhen Wang, Jinghua Liu, Xiaolei Zhang, Zhongxiao Wang, Zhendong Cao, Lijun Lu, Wenbing Lv, Aihui Wang, Shuyan Li, Xiaotian Wu and Xianling Dong
    Citation: EJNMMI Research 2023 13:14
  10. To decipher the relevance of visual and semi-quantitative 6-fluoro-(18F)-L-DOPA (18F-DOPA) interpretation methods for the diagnostic of idiopathic Parkinson disease (IPD) in hybrid positron emission tomography (P...

    Authors: Alex Iep, Mohammad B. Chawki, Lucas Goldfarb, Loc Nguyen, Vincent Brulon, Claude Comtat, Vincent Lebon and Florent L. Besson
    Citation: EJNMMI Research 2023 13:13
  11. Authors: Ramya Ambur Sankaranarayanan, Alexandru Florea, Susanne Allekotte, Andreas T. J. Vogg, Jochen Maurer, Laura Schäfer, Carsten Bolm, Steven Terhorst, Arno Classen, Matthias Bauwens, Agnieszka Morgenroth and Felix M. Mottaghy
    Citation: EJNMMI Research 2023 13:12

    The original article was published in EJNMMI Research 2022 12:60

  12. For positron emission tomography (PET) ligands, such as [11C]ABP688, to be able to provide more evidence about the glutamatergic hypothesis in schizophrenia (SZ), quantification bias during dynamic PET studies an...

    Authors: Cláudia Régio Brambilla, Jürgen Scheins, Lutz Tellmann, Ahlam Issa, Hans Herzog, N. Jon Shah, Irene Neuner and Christoph W. Lerche
    Citation: EJNMMI Research 2023 13:11
  13. To evaluate the utility of 68Ga-DOTATATE and 18F-FDG PET/MR for prediction of grade and stage of pancreatic neuroendocrine tumors (PNETs), and to examine the correlation between parameters obtained from FDG PET a...

    Authors: Jing Gao, Si Xu, Huijun Ju, Yu Pan and Yifan Zhang
    Citation: EJNMMI Research 2023 13:10
  14. 82-Rubidium-Positron emission tomography myocardial perfusion imaging (Rb-PET-MPI) offers higher diagnostic performance for the detection of myocardial ischemia compared to Tc-SPECT-MPI. The aim of this econom...

    Authors: Maroua Mimouni, Julie Bulsei, Meryl Darlington, Candice Estellat, François Rouzet, Fabien Hyafil and Isabelle Durand-Zaleski
    Citation: EJNMMI Research 2023 13:9
  15. Little is known about parameters that have a relevant impact on (dis)similarities in biodistribution between various 68Ga-labeled somatostatin analogues. Additionally, the effect of tumor burden on organ uptake r...

    Authors: Hinke Siebinga, Berlinda J. de Wit-van der Veen, Jos H. Beijnen, Thomas P. C. Dorlo, Alwin D. R. Huitema and Jeroen J. M. A. Hendrikx
    Citation: EJNMMI Research 2023 13:8
  16. Dosimetry in [177Lu]Lu-PSMA therapy is a valuable tool to assess treatment efficacy and toxicity. This study aims to develop a clinically implementable protocol to determine the absorbed dose in organs and tumor ...

    Authors: Steffie M. B. Peters, Maaike C. T. Mink, Bastiaan M. Privé, Maarten de Bakker, Frank de Lange, Constantijn H. J. Muselaers, Niven Mehra, J. Alfred Witjes, Martin Gotthardt, James Nagarajah and Mark W. Konijnenberg
    Citation: EJNMMI Research 2023 13:6
  17. To quantify the relationship between [18F]FDG uptake of the primary tumour measured by PET-imaging with immunohistochemical (IHC) expression of ER, PR, HER2, Ki-67, and clinical subtypes based on these markers...

    Authors: Cornelis M. de Mooij, Roxanne A. W. Ploumen, Patty J. Nelemans, Felix M. Mottaghy, Marjolein L. Smidt and Thiemo J. A. van Nijnatten
    Citation: EJNMMI Research 2023 13:5
  18. In recent years, immune checkpoint inhibitor (ICI) therapy has greatly changed the treatment prospects of patients with non-small cell lung cancer (NSCLC). Among the available ICI therapy strategies, programme...

    Authors: Xiaoqian Zhao, Yan Zhao, Jingmian Zhang, Zhaoqi Zhang, Lihua Liu and Xinming Zhao
    Citation: EJNMMI Research 2023 13:4
  19. Positron emission tomography (PET)/computed tomography (CT) imaging with fluorine-18 (18F)-sodium fluoride (NaF) provides assessment of active vascular microcalcification, but its utility for evaluating diabetes ...

    Authors: Ting-Heng Chou, Eleanor T. Rimmerman, Surina Patel, Molly K. Wynveen, Susan N. Eisert, Kumudha Narayana Musini, Sarah A. Janse, Adam J. Bobbey, Timur P. Sarac, Said A. Atway, Michael R. Go and Mitchel R. Stacy
    Citation: EJNMMI Research 2023 13:3
  20. Radioguided surgery (RGS) has recently emerged as a valuable new tool in the management of recurrent prostate cancer (PCa). After preoperative injection of a 99mTc-labeled prostate-specific membrane antigen (PSMA...

    Authors: Jan-Philip Kunert, Max Müller, Thomas Günther, León Stopper, Nicole Urtz-Urban, Roswitha Beck and Hans-Jürgen Wester
    Citation: EJNMMI Research 2023 13:2
  21. The purpose of this study was to assess the feasibility of using a minimally invasive simultaneous estimation method (SIME) to quantify the binding of the 18-kDa translocator protein tracer [18F]FEPPA. Arterial s...

    Authors: Praveen Dassanayake, Udunna C. Anazodo, Linshan Liu, Lucas Narciso, Maryssa Iacobelli, Justin Hicks, Pablo Rusjan, Elizabeth Finger and Keith St Lawrence
    Citation: EJNMMI Research 2023 13:1
  22. Visual snow syndrome (VSS) is a recently recognized chronic neurologic condition characterized by the constant perceiving of tiny flickering dots throughout the entire visual field. Metabolic overactivity and ...

    Authors: Koen Van Laere, Jenny Ceccarini, Juanito Gebruers, Karolien Goffin and Elizabet Boon
    Citation: EJNMMI Research 2022 12:77
  23. Accurate classification of sites of interest on prostate-specific membrane antigen (PSMA) positron emission tomography (PET) images is an important diagnostic requirement for the differentiation of prostate ca...

    Authors: Kevin H. Leung, Steven P. Rowe, Jeffrey P. Leal, Saeed Ashrafinia, Mohammad S. Sadaghiani, Hyun Woo Chung, Pejman Dalaie, Rima Tulbah, Yafu Yin, Ryan VanDenBerg, Rudolf A. Werner, Kenneth J. Pienta, Michael A. Gorin, Yong Du and Martin G. Pomper
    Citation: EJNMMI Research 2022 12:76
  24. Somatostatin receptor 68Ga PET imaging is standard for evaluation of a patient’s suitability for 177Lu peptide receptor radionuclide therapy of neuroendocrine tumours (NETs). The 68Ga PET serves to ensure suffici...

    Authors: Anna Stenvall, Johan Gustafsson, Erik Larsson, Daniel Roth, Anna Sundlöv, Lena Jönsson, Cecilia Hindorf, Tomas Ohlsson and Katarina Sjögreen Gleisner
    Citation: EJNMMI Research 2022 12:75
  25. Receptor saturation during peptide receptor radionuclide therapy (PRRT) could result in altered [177Lu]Lu-HA-DOTATATE uptake in tumors and organs. Therefore, receptor expression status and effects of different (u...

    Authors: Hinke Siebinga, Chayenne H. A. M. Veerman, Linda de Wit-van der Veen, Marcel P. M. Stokkel, Jeroen J. M. A. Hendrikx and Else A. Aalbersberg
    Citation: EJNMMI Research 2022 12:74
  26. Bayesian penalized likelihood (BPL) algorithm is an effective way to suppress noise in the process of positron emission tomography (PET) image reconstruction by incorporating a smooth penalty. The strength of ...

    Authors: Lei Xu, Can Cui, Rushuai Li, Rui Yang, Rencong Liu, Qingle Meng and Feng Wang
    Citation: EJNMMI Research 2022 12:73
  27. Dopamine transporter (DAT) imaging is used in the diagnostic work-up in suspected parkinsonian syndromes and dementia with Lewy bodies but cannot differentiate between these syndromes, and an extra brain imagi...

    Authors: Susanna Jakobson Mo, Jan Axelsson, Lars Stiernman and Katrine Riklund
    Citation: EJNMMI Research 2022 12:72
  28. Antiepileptic drugs, levetiracetam (LEV) and brivaracetam (BRV), bind to synaptic vesicle glycoprotein 2A (SV2A). In their anti-seizure activity, speed of brain entry may be an important factor. BRV showed fas...

    Authors: Mika Naganawa, Jean-Dominique Gallezot, Sjoerd J. Finnema, Ralph Paul Maguire, Joël Mercier, Nabeel B. Nabulsi, Sophie Kervyn, Shannan Henry, Jean-Marie Nicolas, Yiyun Huang, Ming-Kai Chen, Jonas Hannestad, Henrik Klitgaard, Armel Stockis and Richard E. Carson
    Citation: EJNMMI Research 2022 12:71
  29. Programmed cell death 1 ligand 1(PD-L1) is overexpressed in many tumors. The radionuclide-labeled anti-PD-L1 monoclonal antibody can be used for imaging and therapy of PD-L1 overexpressing cancer. Here, we des...

    Authors: Linhan Zhang, Sheng Zhao, Huijie Jiang, Rongjun Zhang, Mingyu Zhang, Wenbin Pan, Zhongqi Sun, Dandan Wang and Jinping Li
    Citation: EJNMMI Research 2022 12:70
  30. This study aims to analyze the 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) characteristics of different causes of fever of unknown origin (FUO) and identify independen...

    Authors: Jia Chen, MingYou Xing, Dong Xu, NaNa Xie, WenCong Zhang, QiuRong Ruan and JianXin Song
    Citation: EJNMMI Research 2022 12:69
  31. Two commonly used imaging techniques to aid in the diagnosis of neurodegenerative parkinsonian syndromes are dopamine transporter (DAT) imaging with [123I]-FP-CIT single-photon emission computed tomography (DAT-S...

    Authors: Elon Wallert, Erwann Letort, Friso van der Zant, Ania Winogrodzka, Henk Berendse, Martijn Beudel, Rob de Bie, Jan Booij, Pieter Raijmakers and Elsmarieke van de Giessen
    Citation: EJNMMI Research 2022 12:68
  32. Radiopharmaceuticals targeting poly(ADP-ribose) polymerase (PARP) have emerged as promising agents for cancer diagnosis and therapy. PARP enzymes are expressed in both cancerous and normal tissue. Hence, the i...

    Authors: Chung Ying Chan, Samantha L. Hopkins, Florian Guibbal, Anna Pacelli, Julia Baguña Torres, Michael Mosley, Doreen Lau, Patrick Isenegger, Zijun Chen, Thomas C. Wilson, Gemma Dias, Rebekka Hueting, Véronique Gouverneur and Bart Cornelissen
    Citation: EJNMMI Research 2022 12:67
  33. PSMA PET/CT is the recommended imaging test in cases with prostate-specific antigen (PSA) recurrence after primary therapy of prostate cancer (PCa). However, imaging protocols remain a topic of active research...

    Authors: Daniel Koehler, Markus Sauer, Amir Karimzadeh, Ivayla Apostolova, Susanne Klutmann, Gerhard Adam, Sophie Knipper, Tobias Maurer and Christoph Berliner
    Citation: EJNMMI Research 2022 12:66
  34. PSMA-TO-1 (“Tumor-Optimized-1”) is a novel PSMA ligand with longer circulation time than PSMA-617. We compared the biodistribution in subcutaneous tumor-bearing mice of PSMA-TO-1, PSMA-617 and PSMA-11 when lab...

    Authors: Catherine Meyer, Vikas Prasad, Andreea Stuparu, Peter Kletting, Gerhard Glatting, Jonathan Miksch, Christoph Solbach, Katharina Lueckerath, Lea Nyiranshuti, Shaojun Zhu, Johannes Czernin, Ambros J. Beer, Roger Slavik, Jeremie Calais and Magnus Dahlbom
    Citation: EJNMMI Research 2022 12:65
  35. Study of the contribution of microglia to onset and course of several neuropsychiatric conditions is challenged by the fact that these resident immune cells often take on different phenotypes and functions out...

    Authors: Jennifer M. Coughlin, Yong Du, Wojciech G. Lesniak, Courtney K. Harrington, Mary Katherine Brosnan, Riley O’Toole, Adeline Zandi, Shannon Eileen Sweeney, Rehab Abdallah, Yunkou Wu, Daniel P. Holt, Andrew W. Hall, Robert F. Dannals, Lilja Solnes, Andrew G. Horti and Martin G. Pomper
    Citation: EJNMMI Research 2022 12:64
  36. This study aimed to develop a novel analytic approach based on a radiomics model derived from 68Ga-prostate-specific membrane antigen (PSMA)-11 PET/CT for predicting intraprostatic lesions in patients with prosta...

    Authors: Shiming Zang, Shuyue Ai, Rui Yang, Pengjun Zhang, Wenyu Wu, Zhenyu Zhao, Yudan Ni, Qing Zhang, Hongbin Sun, Hongqian Guo, Ruipeng Jia and Feng Wang
    Citation: EJNMMI Research 2022 12:63
  37. CD4+ T cells are central inflammatory mediators in the pathogenesis of autoimmune rheumatoid arthritis (RA), as they are one of the dominating cell types in synovial inflammation. Molecular imaging of CD4+ T cell...

    Authors: Anne Skovsbo Clausen, Camilla Christensen, Esben Christensen, Sigrid Cold, Lotte Kellemann Kristensen, Anders Elias Hansen and Andreas Kjaer
    Citation: EJNMMI Research 2022 12:62
  38. Elastic motion correction in PET has been shown to increase image quality and quantitative measurements of PET datasets affected by respiratory motion. However, little is known on the impact of respiratory mot...

    Authors: Benjamin Noto, Wolfgang Roll, Laura Zinken, Robert Rischen, Laura Kerschke, Georg Evers, Walter Heindel, Michael Schäfers and Florian Büther
    Citation: EJNMMI Research 2022 12:61
  39. Triple-negative breast cancer (TNBC) lacks biomarkers for targeted therapy. Auger emitters display the best therapeutic effect, if delivered directly into the nucleus proximal to DNA. The nuclear protein Poly ...

    Authors: Ramya Ambur Sankaranarayanan, Alexandru Florea, Susanne Allekotte, Andreas T. J. Vogg, Jochen Maurer, Laura Schäfer, Carsten Bolm, Steven Terhorst, Arno Classen, Matthias Bauwens, Agnieszka Morgenroth and Felix M. Mottaghy
    Citation: EJNMMI Research 2022 12:60

    The Correction to this article has been published in EJNMMI Research 2023 13:12

  40. Aggressive B cell lymphoma often requires prompt steroid treatment, even before baseline 18f-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) and definitive treatment, to allevia...

    Authors: Karyn Revital Geiger, Oren Pasvolsky, Tamar Berger, Pia Raanani, Tzippy Shochat, Ronit Gurion, Tamer Anati, David Groshar, Anat Gafter-Gvili and Hanna Bernstine
    Citation: EJNMMI Research 2022 12:59
  41. Clinical prediction models need to be validated. In this study, we used simulation data to compare various internal and external validation approaches to validate models.

    Authors: Jakoba J. Eertink, Martijn W. Heymans, Gerben J. C. Zwezerijnen, Josée M. Zijlstra, Henrica C. W. de Vet and Ronald Boellaard
    Citation: EJNMMI Research 2022 12:58
  42. To explore the feasibility of short-time-window Ki imaging using a population-based arterial input function (IF) and optimized Bayesian penalized likelihood (BPL) reconstruction as a practical alternative to l...

    Authors: Takato Tanaka, Masatoyo Nakajo, Hirofumi Kawakami, Eriko Motomura, Tomofumi Fujisaka, Satoko Ojima, Yasumasa Saigo and Takashi Yoshiura
    Citation: EJNMMI Research 2022 12:57
  43. Dopamine transporter (DAT) imaging of striatum is clinically used in Parkinson’s disease (PD) and neurodegenerative parkinsonian syndromes (PS) especially in the early disease stages. The aim of the present st...

    Authors: Lisbeth Marner, Kirsten Korsholm, Lasse Anderberg, Markus N. Lonsdale, Mads Radmer Jensen, Eva Brødsgaard, Charlotte L. Denholt, Nic Gillings, Ian Law and Lars Friberg
    Citation: EJNMMI Research 2022 12:56

    The Correction to this article has been published in EJNMMI Research 2023 13:19

  44. Our aim was to investigate the discriminative value of 18F-Flutemetamol PET in longitudinal assessment of amyloid beta accumulation in amnestic mild cognitive impairment (aMCI) patients, in relation to longitudin...

    Authors: Elina Rauhala, Jarkko Johansson, Mira Karrasch, Olli Eskola, Tuula Tolvanen, Riitta Parkkola, Kirsi A. Virtanen and Juha O. Rinne
    Citation: EJNMMI Research 2022 12:55
  45. Zirconium-89-immuno-positron emission tomography (89Zr-immuno-PET) has enabled visualization of zirconium-89 labelled monoclonal antibody (89Zr-mAb) uptake in organs and tumors in vivo. Patlak linearization of 89

    Authors: Jessica E. Wijngaarden, Marc C. Huisman, Johanna E. E. Pouw, C. Willemien Menke-van der Houven van Oordt, Yvonne W. S. Jauw and Ronald Boellaard
    Citation: EJNMMI Research 2022 12:54
  46. The NMDA receptor (NMDAR) plays a key role in the central nervous system, e.g., for synaptic transmission. While synaptic NMDARs are thought to have protective characteristics, activation of extrasynaptic NMDA...

    Authors: Lucas Rischka, Matej Murgaš, Verena Pichler, Chrysoula Vraka, Ivo Rausch, Dietmar Winkler, Lukas Nics, Sazan Rasul, Leo Robert Silberbauer, Murray Bruce Reed, Godber Mathis Godbersen, Jakob Unterholzner, Patricia Handschuh, Gregor Gryglewski, Thomas Mindt, Markus Mitterhauser…
    Citation: EJNMMI Research 2022 12:53
  47. This pilot study was designed to evaluate the diagnostic value of 68 Ga-PSMA-617 and 18F-FDG PET/CT in adenoid cystic carcinoma (ACC) and to assess the safety and therapeutic response to PSMA radioligand therapy ...

    Authors: Guochang Wang, Mengjiao Zhou, Jie Zang, Yuanyuan Jiang, Xiaohong Chen, Zhaohui Zhu and Xiaoyuan Chen
    Citation: EJNMMI Research 2022 12:52
  48. Multiple-pinhole (MPH) collimators improve the resolution–sensitivity trade-off compared to parallel-hole collimators. This study evaluated the impact of MPH collimators on intra- and between-rater agreement, ...

    Authors: Franziska Mathies, Ivayla Apostolova, Lena Dierck, Janin Jacobi, Katja Kuen, Markus Sauer, Michael Schenk, Susanne Klutmann, Attila Forgács and Ralph Buchert
    Citation: EJNMMI Research 2022 12:51

EANM'24 - Future Congress!

EANM'24 banner horizontal

Future Congress

37th Annual Congress of the European Association of Nuclear Medicine

October 19 – 23, 2024
Hamburg, Germany

CCH – Congress Center Hamburg
Congressplatz 1
20355 Hamburg, Germany

The EJNMMI Journal Family and EANM Springer Award

New Content Item

EJNMMI is part of the EJNMMI Journal Family. Highlights of our featured content and the latest developments from the EJNMMI group of journals can be found on the EJNMMI Journal Family webpage. There you find details about the annual EANM Springer Prize.

Do you want to publish your paper open access?

Details of the OpenChoice option in EJNMMI are available in the submission guidelines.

If your institution has a Read and Publish (Springer Compact) agreement, you may publish your article open access at no cost to you. In addition, you can enjoy full access to all Springer subscription journal content.

Please check the agreement details by participating country here.